Oncology Ultrasound

Catch up on the top radiology content of the past week.

While the Ovarian-Adnexal Reporting and Data System ultrasound (O-RADS US) system provides a standardized and validated system for classification and risk stratification of ovarian and adnexal masses, a variety of clinical scenarios may prohibit or limit use of the system.

Catch up on the top radiology content of the past week.

A recently published prospective study comparing multiparametric magnetic resonance imaging (MRI) and micro-ultrasound found similar detection rates for prostate cancer.

Catch up on the top radiology content of the past week.

An updated machine learning model demonstrated a 23 percent improvement in accuracy and a 36.1 percent improvement in sensitivity over visual radiologist assessment of ultrasound images for differentiating malignant lymph nodes and benign COVID-19 vaccination-related changes to lymph nodes.

Catch up on the top radiology content of the past week.

While COVID-19 vaccine clinical trials noted that post-vaccine axillary lymphadenopathy lasted for one to 10 days, emerging breast ultrasound research found a mean resolution of 127 days after a first vaccine dose.

Check out top radiology content from the past week.

Based on findings from what may be the first longitudinal study of gallbladder polyps in patients with underlying liver disease, researchers suggested that size change thresholds for cholecystectomy may need to be reevaluated.

The portable ATUSA™ System reportedly provides 3D ultrasound visualization of the entire breast volume in two minutes.

A new study suggests that deep learning algorithms with multimodal ultrasound have comparable specificity and sensitivity to subjective expert assessment and use of the O-RADS classification to distinguish between benign and malignant ovarian tumors.

Validating a prognostic scoring system for locoregional recurrence risk in post-mastectomy patients with varying levels of axillary lymph node involvement, emerging research suggests patients with intermediate risk for breast cancer recurrence could benefit from post-mastectomy radiotherapy.

What is your diagnosis?

Distinguishing between classic and non-classic presentations of isolated adnexal lesions on pelvic ultrasound reportedly had a high specificity and sensitivity in diagnosing ovarian cancer in women at average risk.

In combination with cloud-based data infrastructure and artificial intelligence (AI) applications, handheld ultrasound devices may have the potential to significantly enhance efficiency for providers and contribute to improved patient outcomes.

Emerging research suggests that mammograms should not be delayed for women who develop unilateral lymphadenopathy after receiving COVID-19 vaccines, and that follow-up imaging is unnecessary for patients who have no history of cancer or suspicious concurrent symptoms.

The iBreastExam, a handheld device cleared by the FDA, reportedly enhances routine clinical breast examinations.

Will this artificial intelligence technology improve diagnostic accuracy and reduce false positive biopsy orders?

Breast ultrasound/MRI fusion significantly improves localization of incidentally detected MRI lesions which are occult on an initial ultrasound survey alone.

Investigators at Massachusetts General Hospital proposed an algorithm for appropriate axillary nodal imaging to better align with changes in treatment algorithms for axillary nodal disease in patients with breast cancer.

Position statement supports radiofrequency ablation, cryoablation, and microwave ablation as appropriate image-guided treatment options.

Non-invasive test misses more than four times the number of endometrial cancer cases in Black women than with white counterparts.

Take a quick look at Diagnostic Imaging's Top 5 stories of the week.

Undergoing more frequent abdominal screening can improve life expectancy and quality of life for patients with hepatocellular carcinoma.